Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Fuan Pharmaceutical (Group) Co., Ltd.
—
Fuan Pharmaceutical (Group) Co., Ltd. is led by CEO Lu Wang, employs 2,988 people, headquartered in Chongqing, CN, publicly traded since 2011.
Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) stock trades at $3.72 with a market capitalization of $4.71B. The stock is valued at a price-to-earnings (P/E) ratio of 99.00, price-to-book of 1.17, price-to-sales of 2.84. Over the past 52 weeks the stock has ranged between $3.24 and $5.00, and currently trades 25.6% below its 52-week high. It pays a dividend yielding 1.79%.
On profitability, Fuan Pharmaceutical (Group) Co., Ltd. generates a return on equity (ROE) of 1.34%, an operating margin of 14.36%, a net profit margin of 3.60%.
Official website: www.fapharm.com
Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) — frequently asked questions
What is Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) stock price today?
Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ) is currently trading at $3.72, down 4.86% today.
What is 300194.SZ P/E ratio?
Fuan Pharmaceutical (Group) Co., Ltd.'s P/E ratio is 99.00. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is 300194.SZ return on equity (ROE)?
Fuan Pharmaceutical (Group) Co., Ltd.'s return on equity (ROE) is 1.34%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Fuan Pharmaceutical (Group) Co., Ltd.'s market cap?
Fuan Pharmaceutical (Group) Co., Ltd. has a market capitalization of $4.71B.
Does 300194.SZ pay a dividend?
Yes. Fuan Pharmaceutical (Group) Co., Ltd. currently yields 1.79%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 300194.SZ carry?
Fuan Pharmaceutical (Group) Co., Ltd. has a debt-to-equity ratio of 0.14. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 300194.SZ's profit margin?
Fuan Pharmaceutical (Group) Co., Ltd. reports a net profit margin of 3.60% — the share of revenue left after every cost, including tax and interest.
What sector is 300194.SZ in?
Fuan Pharmaceutical (Group) Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 300194.SZ listed on?
Fuan Pharmaceutical (Group) Co., Ltd. trades on SHZ under the ticker 300194.SZ.
What is 300194.SZ's 52-week range?
Over the last year Fuan Pharmaceutical (Group) Co., Ltd. has traded between $3.24 and $5.00.
Related — Stocks
Popular Stocks
Screens 300194.SZ currently matches
On the figures above, Fuan Pharmaceutical (Group) Co., Ltd. passes the filters for 11 of our ready-made screens, among them Dividend Stocks, Low Debt Stocks, Penny Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.